Placeholder Banner

BIO Letter to Angela Merkel on the Benefits of Biotech

July 15, 2021

As you prepare for Chancellor Merkel’s visit to Washington, we, the representatives of America’s biotechnology sector thought that you and your government might benefit from an update on all that our sector is doing globally to address the ongoing COVID crisis, and in particular to ensure that patients in low-and middle-income countries get quick, safe access to COVID vaccines. The Biotechnology Innovation Organization (BIO) is the world’s largest biotechnology organization, with about 1000 members of all sizes, but most of whom are small and medium sized companies. BIO also has an extensive network of relationships with biotechnology associations around the world, including those in Germany.

Download Full Comments Below
BIO Letter to Angela Merkel
Discover More
On Wednesday, December 29th, BIO submitted comments to the Food and Drug Administration’s recent draft guidance for industry entitled, Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the Federal Food, Drug, and…
On Monday, December 13th, BIO submitted comments to the Food and Drug Administration’s recent draft guidance for industry entitled, Q13 Continuous Manufacturing of Drug Substances and Drug Products. The draft guidance was prepared under the auspices…
On Monday, November 8th, BIO submitted comments to the FDA’s draft guidance on Nonclinical Biodistribution Considerations for Gene Therapy Products. In the comment letter, BIO expressed appreciation for the Agency’s decision to put forth a draft…